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marrow mononuclear cells in a murine acute
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S.-Z. Jin1 *, X.-W. Meng1, X. Sun2, M.-Z. Han3, B.-R. Liu3,
X.-H. Wang1, F.-H. Pei1. 1Department of Gastroenterology,
The First Hospital, Jilin University, 2Department of
Pathology, The First Hospital, Jilin University, 3Department
of Gastroenterology, The Second Afﬁliated Hospital, Harbin
Medical University, China
Background: Bone marrow mononuclear cells (BMMCs)
transplantation is a potential therapy for acute liver failure;
however, its therapeutic efﬁcacy requires improvement.
Methods: We established a murine acute liver failure
model induced by CCl4 administration. The effect of
BMMCs transplantation in combination with hepatocyte
growth factor (HGF) was studied. Recipient mice were
transfused with PKH26-labeled BMMCs (5×106) with HGF
(50 ng/kg.d ×7 days) (BMMCs + HGF group). BMMCs
only, HGF alone, and 0.9% NaCl alone were included
as control groups. To assess the effect of donor BMMCs
in liver regeneration, quantitative image analysis with
immunohistochemistry for PKH26, proliferating cell nuclear
antigen (PCNA), and albumin expression was performed
after transplantation.
Result: PKH26 positive cells were detected in liver tissues,
and most of them expressed PCNA. The expression of
PCNA and albumin in BMMCs + HGF groups increased
signiﬁcantly compared with three control groups. Liver
function, as monitored by serum aminotransferase activity,
was signiﬁcantly improved in the BMMCs + HGF group
compared with the control groups.
Conclusion: In summary, this study suggests that BMMC
transplantation combined with HGF has much higher
therapeutic efﬁcacy and may become a safe and efﬁcient
strategy for treatment of acute liver failure in clinical
practice.
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Background: Extended spectrum b-lactamases (ESBLs)
mediates resistance to new generation of cephalosporins. In
the present study we investigate the antibiotic susceptibility
and the prevalence of the antibiotic resistance genes in
clinical ESBL-producing Klebsiella pneumoniae isolates from
the ICU of Neonatology Department, the First Afﬁlated
Hospital of Nanchang University.
Methods: The clinical isolates of Klebsiella pneumoniae
were obtained during November 2009 to February 2010. The
strains were identiﬁed by VITEK-2 System and the antibiotic
susceptibility patterns of isolates were determined by
Kirby-Bauer method. Phenotypic conﬁrmatory test (PCT)
was carried out for screening of ESBLs. Subsequently, the
isolates were subjected to polymerase chain reaction (PCR)
targeting blaCTX-M, blaTEM, blaSHV, blaPER-1, blaVEB, blaGES and
blaOXA genes.
Results: The most ESBL-producing Klebsiella pneumoniae
isolates showed the least sensitivity to ampicillin and
cefazolin (0.00% and 2.13%); they showed highest
susceptibilty to Imipenem (97.97%) followed by meropenem
(97.87%), ertapenem (93.75), tetracycline (70.21%),
ceftazidime (31.91%), amikacin (31.25%), levoﬂoxacin
(31.25%), SMZco (31.25%), ciproﬂoxacin (29.17%), aztreonam
(23.40%), cefepime (21.28%), piperacillin (12.77%),
ceftriaxone (10.64%), amoxicillin/clavulanic (10.64%) and
gentamicin (10.42%). Of the 47 ESBL-producing Klebsiella
pneumoniae strains, 30 were blaCTX-M positive, 14 were
blaSHV positive, and 12 were blaTEM positive, 6 were blaGES
positive, only 1 was blaPER-1 positive, and 3 were negative.
Additionally, the blaGES positive strains were all harboring
blaCTX-M gene.
Conclusions: The ESBL genes have high prevalence among
clinical isolates of Klebsiella pneumoniae in the ICU
of Neonatology Department. ESBL-producing Klebsiella
pneumoniae had excellent susceptibility to carbapenem
antibiotics and the drug susceptibility of the rest antibiotics
except tetracycline was lower than 40%. Among the
b-Lactamase resistance genes, blaCTX-M was the most
common one. Furthermore, 74% of ESBLs carry at least two
b-Lactamase resistance genes.
